Beam Therapeutics Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Beam Therapeutics Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $1.51M, a 0.60% increase year-over-year.
- Beam Therapeutics Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $1.26M, a 3.19% increase year-over-year.
- Beam Therapeutics Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-03-31 was $1.50M, a 7.37% increase year-over-year.
- Beam Therapeutics Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-09-30 was $1.22M, a 7.55% decline year-over-year.
- Beam Therapeutics Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $2.76M, a 5.46% increase from fiscal 2024.
- Beam Therapeutics Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $2.62M, a 13.56% decline from fiscal 2023.
- Beam Therapeutics Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $3.03M, a 1.40% decline from fiscal 2022.
- Beam Therapeutics Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $3.08M.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-03-31 | $1.51M 10-Q · filed 2026-08-04 | |
| 2025-12-31 | $2.76M 10-K · filed 2026-02-24 | |
| 2025-09-30 | $1.26M 10-Q · filed 2025-11-04 | |
| 2025-03-31 | $1.50M 10-Q · filed 2026-08-04 | |
| 2024-12-31 | $2.62M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $1.22M 10-Q · filed 2025-11-04 | |
| 2024-03-31 | $1.40M 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $3.03M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $1.32M 10-Q · filed 2024-11-05 | |
| 2023-03-31 | $1.71M 10-Q · filed 2024-11-05 | |
| 2022-12-31 | $3.08M 10-K · filed 2025-02-25 | |
| 2022-09-30 | $1.66M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $1.41M 10-Q · filed 2023-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |